SEC Must Decide On Teva Whistleblower Award, DC Circ. Told
Law360 (May 1, 2019, 8:47 PM EDT) -- A purported whistleblower who claims to have alerted the U.S. Securities and Exchange Commission to misconduct by Teva Pharmaceutical Industries Ltd. eight years ago has accused the securities regulator of taking too long to decide whether to issue an award.
The unnamed petitioner asked the D.C. Circuit on Monday to require the U.S. Securities and Exchange Commission to preliminarily decide within 60 days whether to grant a monetary award for supposedly alerting the regulator to misconduct that resulted in a $519 million deal, according to a petition for writ of mandamus.
The petitioner called the delay unreasonable, but Rebecca Katz, an...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!